AT344188B - Verfahren zur herstellung von neuen morpholinderivaten und von ihren saeureadditionssalzen - Google Patents

Verfahren zur herstellung von neuen morpholinderivaten und von ihren saeureadditionssalzen

Info

Publication number
AT344188B
AT344188B AT341575A AT341575A AT344188B AT 344188 B AT344188 B AT 344188B AT 341575 A AT341575 A AT 341575A AT 341575 A AT341575 A AT 341575A AT 344188 B AT344188 B AT 344188B
Authority
AT
Austria
Prior art keywords
acid addition
addition salts
producing new
morpholine derivatives
new morpholine
Prior art date
Application number
AT341575A
Other languages
English (en)
Other versions
ATA341575A (de
Inventor
Bernard J Mcloughlin
Allen J Guildford
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Priority to AT266877A priority Critical patent/AT344714B/de
Priority to AT266977A priority patent/AT344715B/de
Publication of ATA341575A publication Critical patent/ATA341575A/de
Application granted granted Critical
Publication of AT344188B publication Critical patent/AT344188B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/321,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/04Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/6533Six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT341575A 1974-05-07 1975-05-05 Verfahren zur herstellung von neuen morpholinderivaten und von ihren saeureadditionssalzen AT344188B (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AT266877A AT344714B (de) 1974-05-07 1977-04-15 Verfahren zur herstellung von neuen morpholinderivaten und von ihren saeureadditionssalzen
AT266977A AT344715B (de) 1974-05-07 1977-04-15 Verfahren zur herstellung eines neuen morpholinderivates und von dessen saeureadditionssalzen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2001374A GB1452701A (en) 1974-05-07 1974-05-07 Morpholine derivatives
JP2495676A JPS52139074A (en) 1974-05-07 1976-03-08 Morpholine derivative and mental version drug composition containing same

Publications (2)

Publication Number Publication Date
ATA341575A ATA341575A (de) 1977-11-15
AT344188B true AT344188B (de) 1978-07-10

Family

ID=26254367

Family Applications (1)

Application Number Title Priority Date Filing Date
AT341575A AT344188B (de) 1974-05-07 1975-05-05 Verfahren zur herstellung von neuen morpholinderivaten und von ihren saeureadditionssalzen

Country Status (20)

Country Link
US (1) US4010266A (de)
JP (2) JPS50154273A (de)
AR (1) AR209436A1 (de)
AT (1) AT344188B (de)
BE (1) BE828822A (de)
CA (1) CA1067075A (de)
CH (2) CH610894A5 (de)
DD (1) DD121641A5 (de)
DE (1) DE2519101A1 (de)
DK (1) DK198675A (de)
FI (1) FI751344A (de)
FR (1) FR2269953B1 (de)
GB (1) GB1452701A (de)
HK (1) HK5580A (de)
IN (1) IN141021B (de)
KE (1) KE3021A (de)
LU (1) LU72408A1 (de)
NL (1) NL7505140A (de)
SE (1) SE425312B (de)
ZA (1) ZA752388B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4088814A (en) * 1974-05-07 1978-05-09 Imperial Chemical Industries Limited Morpholine derivatives
JPS5266991U (de) * 1975-11-13 1977-05-18
AU508678B2 (en) * 1976-07-14 1980-03-27 Imperial Chemical Industries Limited Anorexiants
IE50355B1 (en) * 1979-10-20 1986-04-02 Wyeth John & Brother Ltd Morpholine derivatives
WO1993015052A1 (en) * 1992-01-28 1993-08-05 Smithkline Beecham Plc Compounds as calcium channel antagonists
US6048859A (en) 1992-06-29 2000-04-11 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
US5719147A (en) * 1992-06-29 1998-02-17 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
US5637699A (en) * 1992-06-29 1997-06-10 Merck & Co., Inc. Process for preparing morpholine tachykinin receptor antagonists
TW385308B (en) * 1994-03-04 2000-03-21 Merck & Co Inc Prodrugs of morpholine tachykinin receptor antagonists
WO1998007710A1 (en) * 1996-08-23 1998-02-26 Neurosearch A/S Disubstituted morpholine, oxazepine or thiazepine derivatives, their preparation and their use as dopamine d4 receptor antagonists
CA2422055A1 (en) 2000-09-11 2002-03-21 Sepracor, Inc. Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
US7294637B2 (en) 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2255077A (en) * 1938-03-21 1941-09-09 Du Pont Film Mfg Corp Filter dyes for color photography

Also Published As

Publication number Publication date
IN141021B (de) 1977-01-08
ATA341575A (de) 1977-11-15
JPS52139074A (en) 1977-11-19
FI751344A (de) 1975-11-08
SE7505237L (sv) 1975-11-10
DK198675A (da) 1975-11-08
SE425312B (sv) 1982-09-20
LU72408A1 (de) 1976-11-11
GB1452701A (en) 1976-10-13
DE2519101A1 (de) 1975-11-20
JPS50154273A (de) 1975-12-12
AR209436A1 (es) 1977-04-29
DD121641A5 (de) 1976-08-12
CA1067075A (en) 1979-11-27
CH610894A5 (de) 1979-05-15
US4010266A (en) 1977-03-01
NL7505140A (nl) 1975-11-11
CH634569A5 (de) 1983-02-15
FR2269953B1 (de) 1978-10-06
AU8021575A (en) 1976-10-21
HK5580A (en) 1980-02-29
FR2269953A1 (de) 1975-12-05
BE828822A (fr) 1975-11-07
KE3021A (en) 1980-03-14
ZA752388B (en) 1976-03-31

Similar Documents

Publication Publication Date Title
AT352127B (de) Verfahren zur herstellung von neuen 1- substituierten-4-benzylpiperidinen und ihren saeureadditionssalzen
AT356091B (de) Verfahren zur herstellung von neuen heterocyclisch substituierten 5-sulfamoyl- benzoesaeurederivaten und ihren salzen
ATA942975A (de) Verfahren zur herstellung von neuen 1-substituierten-4-benzylidenpiperidene und ihren salzen
AT345833B (de) Verfahren zur herstellung von neuen benzimidazolinon-derivaten und ihren saeure- additionssalzen
AT358035B (de) Verfahren zur herstellung von neuen indolizin- derivaten und von ihren saeureadditionssalzen
AT344188B (de) Verfahren zur herstellung von neuen morpholinderivaten und von ihren saeureadditionssalzen
AT348518B (de) Verfahren zur herstellung von neuen 2-thiol- 4,5-diphenyloxazol-s-derivaten und ihren salzen
AT343118B (de) Verfahren zur herstellung von neuen thienotriazolodiazepin-derivaten und ihren salzen
AT347946B (de) Verfahren zur herstellung von neuen 1h- tetrazolderivaten und ihren salzen
AT353257B (de) Verfahren zur herstellung von neuen dibenzo- furanderivaten und ihren salzen
AT356110B (de) Verfahren zur herstellung von neuen benzyliso- chinolinderivaten und ihren saeureadditions- salzen
AT340912B (de) Verfahren zur herstellung von neuen amidoxim-derivaten und ihren saureadditionssalzen
ATA307175A (de) Verfahren zur herstellung von neuen prostansaeurederivaten und von ihren salzen
ATA606175A (de) Verfahren zur herstellung von neuen prostansaeurederivaten und von ihren salzen
AT345295B (de) Verfahren zur herstellung von neuen piperazinderivaten und ihren salzen
ATA385775A (de) Verfahren zur herstellung von neuen thiophenderivaten und ihren salzen
ATA46475A (de) Verfahren zur herstellung von neuen phentiazinderivaten und von ihren saureadditionssalzen
AT353792B (de) Verfahren zur herstellung von neuen chinolin- derivaten und ihren saeureadditionssalzen
AT341529B (de) Verfahren zur herstellung von neuen azatetracyclen und ihren salzen
ATA385675A (de) Verfahren zur herstellung von neuen thiophenderivaten und ihren salzen
AT342601B (de) Verfahren zur herstellung von neuen piperazinderivaten und deren salzen
AT357535B (de) Verfahren zur herstellung von neuen 4-amino- transdecahydrochinolinderivaten und ihren saeureadditionssalzen
AT351536B (de) Verfahren zur herstellung von neuen benzo (c) (1,6)-naphthyridin-derivaten und ihren saeure- additonssalzen
AT347460B (de) Verfahren zur herstellung von neuen alpha,alpha - diaryl- beta - amino-propanolen und ihren saeureadditionssalzen
AT345293B (de) Verfahren zur herstellung von neuen 1-alkenyl-3a-m-substituiertes-phenyl-decahydroisochinolinen und ihren saeureaddtionssalzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELJ Ceased due to non-payment of the annual fee